Skip to content
Screener
Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$15.87M+8.8%-$17.96M-12.8%-$9.39M-1,775%-$16.29M-6.0%-$17.4M+18.0%
$1.89M-26.7%$899K-63.5%$2.81M+25.5%$2.78M+28.8%$2.58M+21.7%
$6.46M-32.5%$8.03M-7.6%$7.56M-11.7%$8M+1.2%$9.58M+42.1%
$7.24M+72.5%-$8.03M-90.8%-$9.09M+23.2%-$3.05M+78.1%
$2.2M-53.8%$3.06M-13.6%$2.4M-22.0%$2.81M-1.9%$4.77M+176%
-$7.82M-313%$9.67M+183%$8.74M+51.6%-$3.26M-115%
$696K-29.5%-$588K-109%$1.38M+5,215%$0-100%$987K+217%
$3.07M+158%-$1.16M-158%-$366K+94.0%-$5.32M-160%
-$6.9M+11.7%$4.18M+538%-$10.42M-43.2%-$11.9M+19.1%-$7.82M+50.0%

FAQ

What is Treace Medical Concepts, Inc.'s free cash flow?
After $10.5M of capital expenditures, Treace Medical Concepts, Inc.'s free cash flow was -$25.0M over the trailing twelve months, up 14.1% year over year.
Where does Treace Medical Concepts, Inc.'s cash flow data come from?
Every line is extracted from Treace Medical Concepts, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.